Product category:
Microplates/microarrays and readers
News Release from: Oxford Gene Technology
Edited by the Laboratorytalk Editorial
Team on 09 January 2007
OGT and Nimblegen reach oligonucleotide
agreements
NimbleGen has obtained a license to Oxford Gene Technology (OGT)'s Southern array patents, the fundamental patents covering the manufacture and commercialisation of oligonucleotide arrays
At the same time the companies entered into a supply agreement under which OGT will be able to obtain DNA microarrays from NimbleGen for use in OGT's service business, and NimbleGen will be able to make and sell OGT-designed arrays Terms of the agreements were not disclosed
This article was originally published on Laboratorytalk on 12 Sep 2006 at 8.00am (UK)
Related stories
OGT extends its Chip2 microarray family
Oxford Gene Technology (OGT) has extended its Chip2 family of ChIP on chip microarray products with the addition of four prokaryote species
"Successful discussions with NimbleGen have concluded with the granting of this license thus enabling NimbleGen to deliver their microarray products and services worldwide and adding to OGT's growing portfolio of North American licensees," stated Sue Sutton, vice president licensing North America at OGT.
"We are also looking forward to being able to offer NimbleGen's high-density microarrays within our microarray service business".
Stan Rose, president and CEO of NimbleGen, said, "NimbleGen has long been an admirer of the work of Professor Ed Southern, and we're delighted to have expanded our relationship with these new agreements.
"They provide NimbleGen with access to important intellectual property rights relevant to our core business, as well as an exciting new commercial relationship that should benefit both companies.".
• Oxford Gene Technology: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
